Impact BioMedical, Inc.
Symbol: IBO (NYSE)
0.65
▼ (-1.93%) -0.013
Company Description:
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Key Stats
- Today's Open: $0.653
- Today's High: $0.691
- Today's Low: $0.652
- Today's Volume: 5.72K
- Yesterday Close: $0.6648
- Yesterday High: $0.6648
- Yesterday Low: $0.633
- Yesterday Volume: 50.46K
- Last Min Volume: 1.65K
- Last Min High: $0.654
- Last Min Low: $0.652
- Last Min VWAP: $0.65296
Company Profile
- Name: Impact BioMedical, Inc.
- Website: https://www.impactbiomedinc.com
- Listed Date: 2024-09-16
- Location: HOUSTON, TX
- Market Status: Active
- CIK Number: 0001834105
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $8.10M
- Round Lot: 100
- Outstanding Shares: 12.19M
- Asset Type: CS
RECENT FILINGS FOR IBO
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-22 | DEF 14A | View |
| 2025-09-09 | DEF 14C | View |
| 2025-08-25 | PRE 14C | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-05 | DEF 14C | View |
| 2025-07-28 | 8-K | View |
| 2025-07-16 | PRE 14C | View |
| 2025-06-23 | 8-K | View |
| 2025-05-27 | 4 | View |
| 2025-05-14 | 10-Q | View |
| 2025-04-07 | 4 | View |
| 2025-04-07 | 4 | View |
| 2025-04-04 | 4 | View |
| 2025-04-04 | SCHEDULE 13D/A | View |
| 2025-04-03 | 8-K | View |
| 2025-04-02 | SCHEDULE 13D | View |
| 2025-04-02 | 4 | View |
| 2025-03-28 | 4 | View |
| 2025-03-28 | 10-K | View |
| 2025-03-28 | 8-K | View |
Latest News on IBO